Research
Metabolic adaptation
Endpoints predominantly driven by liraglutide-induced weight loss include waist circumference, diastolic blood pressure, triglycerides, high density lipoprotein cholesterol, AHI, and health-related quality of life scores.
Liraglutide treatment can lead to improvements in various health metrics related to weight loss.
StrongSupportsmedium confidence
Endpoints predominantly driven by liraglutide-induced weight loss included waist circumference, diastolic blood pressure, triglycerides, high density lipoprotein cholesterol, AHI, and Impact of Weight on Quality of Life-Lite total and physical function scores.
Why this rating
Derived from a large analysis of trial data.
Source
Liraglutide 3.0 mg for weight management: weight-loss dependent and independent effects
Harold Bays et al. · Current Medical Research and Opinion · 2016
DOI 10.1080/03007995.2016.1251892
rct · n=4725Cited 48×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Treatment with liraglutide 3.0 mg provides a statistically significant and clinically meaningful weight loss of 5.7%-8.0% compared to 1.6%-2.6% with placebo.Strong
- Endpoints predominantly independent of weight loss include hemoglobin A1c and fasting plasma glucose in individuals with and without T2DM.Strong
Related findings · Metabolic adaptation
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →